{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:41Z","timestamp":1792547501067,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/JRF-2015\/HRD-LS\/72\/92467\/133"],"award-info":[{"award-number":["3\/1\/3\/JRF-2015\/HRD-LS\/72\/92467\/133"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["(31\/014(2683)\/2016-EMR-1)"],"award-info":[{"award-number":["(31\/014(2683)\/2016-EMR-1)"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["IF160504"],"award-info":[{"award-number":["IF160504"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12012-019-09548-3","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:06:55Z","timestamp":1567584415000},"page":"235-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4\/NF-\u03baB Pathway in Mice"],"prefix":"10.1007","volume":"20","author":[{"given":"Nasiruddin","family":"Nalban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Sangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateesh","family":"Alavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Mukhtar","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh Kumar","family":"Jerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Sistla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"2","key":"9548_CR1","first-page":"S5","volume":"10","author":"Christi Deatona","year":"2011","unstructured":"Deatona, Christi, Froelicher, Erika Sivarajan, Wuc, Lai Har, Hod, Camille, Shishani, Kawkab, & Jaarsmaf, Tiny. (2011). The global burden of cardiovascular disease. European Journal of Cardiovascular Nursing,10(2), S5\u2013S13.","journal-title":"European Journal of Cardiovascular Nursing"},{"key":"9548_CR2","unstructured":"https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)"},{"issue":"4","key":"9548_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","volume":"61","author":"A Rohini","year":"2010","unstructured":"Rohini, A., Agrawal, N., Koyani, C. N., & Singh, R. (2010). Molecular targets and regulators of cardiac hypertrophy. Pharmacological Research,61(4), 269\u2013280.","journal-title":"Pharmacological Research"},{"issue":"2","key":"9548_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.0000053618.86362.DF","volume":"92","author":"B Nadal-Ginard","year":"2003","unstructured":"Nadal-Ginard, B., Kajstura, J., Leri, A., & Anversa, P. (2003). Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circulation Research,92(2), 139\u2013150.","journal-title":"Circulation Research"},{"key":"9548_CR5","first-page":"392","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Xu, J., Long, Z., Wang, C., Wang, L., Sun, P., et al. (2016). Hydrogen (H2) inhibits isoproterenol-induced cardiac hypertrophy via antioxidative pathways. Frontiers in Pharmacology,7, 392.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"9548_CR6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000006743","volume":"89","author":"YL Ho","year":"1998","unstructured":"Ho, Y. L., Wu, C. C., Lin, L. C., Huang, C. H., Chen, W. J., Chen, M. F., et al. (1998). Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with the dobutamine-atropine stress echocardiography: Effect of the left ventricular hypertrophy. Cardiology,89(1), 52\u201358.","journal-title":"Cardiology"},{"issue":"4","key":"9548_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","volume":"40","author":"JM Li","year":"2002","unstructured":"Li, J. M., Gall, N. P., Grieve, D. J., Chen, M., & Shah, A. M. (2002). Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension,40(4), 477\u2013484.","journal-title":"Hypertension"},{"issue":"15","key":"9548_CR8","first-page":"1754","volume":"18","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Zhang, X. J., & Li, H. (2017). Targeting interferon regulatory factor for cardiometabolic diseases: Opportunities and challenges. Current Drug Targets,18(15), 1754\u20131778.","journal-title":"Current Drug Targets"},{"issue":"2","key":"9548_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/187152908784533702","volume":"8","author":"SH Gutierrez","year":"2008","unstructured":"Gutierrez, S. H., Kuri, M. R., & del Castillo, E. R. (2008). Cardiac role of the transcription factor NF-\u03baB. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular &Hematological Disorders),8(2), 153\u2013160.","journal-title":"Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular &Hematological Disorders)"},{"issue":"11","key":"9548_CR10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","volume":"131","author":"RA Frieler","year":"2015","unstructured":"Frieler, R. A., & Mortensen, R. M. (2015). Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation,131(11), 1019\u20131030.","journal-title":"Circulation"},{"issue":"3","key":"9548_CR11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jep.2013.10.017","volume":"150","author":"J Yang","year":"2013","unstructured":"Yang, J., Wang, H. X., Zhang, Y. J., Yang, Y. H., Lu, M. L., Zhang, J., et al. (2013). Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4\/NF-\u043aBsignaling pathway in isoproterenol-induced myocardial hypertrophy. Journal of Ethnopharmacology,150(3), 1062\u20131070.","journal-title":"Journal of Ethnopharmacology"},{"issue":"8","key":"9548_CR12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s12272-016-0806-9","volume":"39","author":"A Achek","year":"2016","unstructured":"Achek, A., Yesudhas, D., & Choi, S. (2016). Toll-like receptors: Promising therapeutic targets for inflammatory diseases. Archives of Pharmacal Research,39(8), 1032\u20131049.","journal-title":"Archives of Pharmacal Research"},{"key":"9548_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.intimp.2017.12.019","volume":"55","author":"D Ma","year":"2018","unstructured":"Ma, D., Zhang, J., Zhang, Y., Zhang, X., Han, X., Song, T., et al. (2018). Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4\/NF-\u03baB signaling pathway in mice. International Immunopharmacology,55, 237\u2013244.","journal-title":"International Immunopharmacology"},{"key":"9548_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","volume":"8","author":"PB Katare","year":"2017","unstructured":"Katare, P. B., Bagul, P. K., Dinda, A. K., & Banerjee, S. K. (2017). Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats. Frontiers in Immunology,8, 719.","journal-title":"Frontiers in Immunology"},{"key":"9548_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jep.2016.12.050","volume":"198","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Alam, M. J., Prabhakar, P., Ahmad, S., Maulik, S. K., Sharma, M., et al. (2017). Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna (Roxb.) on isoproterenol-induced cardiac hypertrophy in rats. Journal of Ethnopharmacology,198, 98\u2013108.","journal-title":"Journal of Ethnopharmacology"},{"key":"9548_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-018-9470-2","author":"B Sharma","year":"2018","unstructured":"Sharma, B., Chaube, U., & Patel, B. M. (2018). Beneficial effect of silymarin in pressure overload induced experimental cardiac hypertrophy. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-018-9470-2 .","journal-title":"Cardiovascular Toxicology"},{"issue":"3","key":"9548_CR17","doi-asserted-by":"crossref","first-page":"e0118759","DOI":"10.1371\/journal.pone.0118759","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang, S., Tang, F., Yang, Y., Lu, M., Luan, A., Zhang, J., et al. (2015). Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-\u03baB\/PGC-1\u03b1 signaling mediated energy biosynthesis. PLoS ONE,10(3), e0118759.","journal-title":"PLoS ONE"},{"key":"9548_CR18","doi-asserted-by":"crossref","DOI":"10.1002\/9781118543436","volume-title":"Phytopharmacy: An evidence-based guide to herbal medicinal products","author":"SE Edwards","year":"2015","unstructured":"Edwards, S. E., Rocha, I., Heinrich, M., & Williamson, E. M. (2015). Phytopharmacy: An evidence-based guide to herbal medicinal products. Chichester: Wiley."},{"key":"9548_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phytol.2015.05.015","volume":"13","author":"P Migas","year":"2015","unstructured":"Migas, P., & Krauze-Baranowska, M. (2015). The significance of Arbutin and its derivatives in therapy and cosmetics. Phytochemistry Letters,13, 35\u201340.","journal-title":"Phytochemistry Letters"},{"key":"9548_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2018.11.038","volume":"146","author":"SR Ahmadian","year":"2019","unstructured":"Ahmadian, S. R., GhaS, E., Mi-Kasman, M., Pouramir, M., & Sadeghi, F. (2019). Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy. Neuropharmacology,146, 117\u2013127.","journal-title":"Neuropharmacology"},{"issue":"1","key":"9548_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jep.2012.02.030","volume":"141","author":"MME Taha","year":"2012","unstructured":"Taha, M. M. E., Salga, M. S., Ali, H. M., Abdulla, M. A., Abdelwahab, S. I., & Hadi, A. H. A. (2012). Gastroprotective activities of Turnera diffusa Willd. exSchult. revisited: Role of Arbutin. Journal of Ethnopharmacology,141(1), 273\u2013281.","journal-title":"Journal of Ethnopharmacology"},{"issue":"11","key":"9548_CR22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s10495-014-1032-x","volume":"19","author":"LH Wu","year":"2014","unstructured":"Wu, L. H., Li, P., Zhao, Q. L., Piao, J. L., Jiao, Y. F., Kadowaki, M., et al. (2014). Arbutin, an intracellular hydroxyl radical scavenger, protects radiation-induced apoptosis in human lymphoma U937 cells. Apoptosis,19(11), 1654\u20131663.","journal-title":"Apoptosis"},{"issue":"8","key":"9548_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00011-012-0474-2","volume":"61","author":"HJ Lee","year":"2012","unstructured":"Lee, H. J., & Kim, K. W. (2012). Anti-inflammatory effects of Arbutin in lipopolysaccharide-stimulated BV2 microglial cells. Inflammation Research,61(8), 817\u2013825.","journal-title":"Inflammation Research"},{"issue":"6","key":"9548_CR24","first-page":"533","volume":"8","author":"M Dadgar","year":"2018","unstructured":"Dadgar, M., Pouramir, M., Dastan, Z., Ghasemi-Kasman, M., Mi-Kasman, M., Ashrafpour, M., et al. (2018). Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson\u2019s disease. Avicenna Journal of Phytomedicine,8(6), 533.","journal-title":"Avicenna Journal of Phytomedicine"},{"issue":"9","key":"9548_CR25","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1039\/C8FO00688A","volume":"9","author":"N Zhou","year":"2018","unstructured":"Zhou, N., Zeng, M. N., Li, K., Yang, Y. Y., Bai, Z. Y., Zheng, X. K., et al. (2018). An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy. Food & Function,9(9), 4989\u20134997.","journal-title":"Food & Function"},{"key":"9548_CR26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopha.2016.10.030","volume":"84","author":"S Patel","year":"2016","unstructured":"Patel, S. (2016). Plant-derived cardiac glycosides: Role in heart ailments and cancer management. Biomedicine & Pharmacotherapy,84, 1036\u20131041.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9548_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pupt.2018.12.001","volume":"54","author":"Jinyan Ye","year":"2019","unstructured":"Ye, Jinyan, Guan, Minqiang, Yao, Lu, Zhang, Dan, Li, Chengye, & Zhou, Caicun. (2019). Arbutin attenuates LPS-induced lung injury via Sirt1\/Nrf2\/NF-\u03baBp65 pathway. Pulmonary Pharmacology & Therapeutics,54, 53\u201359.","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"1","key":"9548_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2014.02.022","volume":"277","author":"BD Sahu","year":"2014","unstructured":"Sahu, B. D., Tatireddy, S., Koneru, M., Borkar, R. M., Kumar, J. M., Kuncha, M., et al. (2014). Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: Possible mechanism of nephroprotection. Toxicology and Applied Pharmacology,277(1), 8\u201320.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9548_CR29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopha.2018.01.169","volume":"100","author":"SM Mir","year":"2018","unstructured":"Mir, S. M., Ravuri, H. G., Pradhan, R. K., Narra, S., Kumar, J. M., Kuncha, M., et al. (2018). Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb\/c mice. Biomedicine & Pharmacotherapy,100, 304\u2013315.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"9548_CR30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry,95(2), 351\u2013358.","journal-title":"Analytical Biochemistry"},{"key":"9548_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jnutbio.2015.10.004","volume":"28","author":"BD Sahu","year":"2016","unstructured":"Sahu, B. D., Kumar, J. M., & Sistla, R. (2016). Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: Relevance of NF-\u03baB signaling. The Journal of Nutritional Biochemistry,28, 171\u2013182.","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"01","key":"9548_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1142\/S0192415X16500051","volume":"44","author":"YL Yeh","year":"2016","unstructured":"Yeh, Y. L., Tsai, H. I., Cheng, S. M., Pai, P., Ho, T. J., Chen, R. J., et al. (2016). Mechanism of Taiwan Mingjian Oolong tea to inhibit isoproterenol-induced hypertrophy and apoptosis in cardiomyoblasts. The American Journal of Chinese Medicine,44(01), 77\u201386.","journal-title":"The American Journal of Chinese Medicine"},{"issue":"11","key":"9548_CR33","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/bph.13091","volume":"172","author":"XJ Feng","year":"2015","unstructured":"Feng, X. J., Gao, H., Gao, S., Li, Z., Li, H., Lu, J., et al. (2015). The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1. British Journal of Pharmacology,172(11), 2852\u20132863.","journal-title":"British Journal of Pharmacology"},{"issue":"1\u20133","key":"9548_CR34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2009.04.061","volume":"615","author":"SB Wang","year":"2009","unstructured":"Wang, S. B., Tian, S., Yang, F., Yang, H. G., Yang, X. Y., & Du, G. H. (2009). Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. European Journal of Pharmacology,615(1\u20133), 125\u2013132.","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"9548_CR35","doi-asserted-by":"crossref","first-page":"e48872","DOI":"10.1371\/journal.pone.0048872","volume":"7","author":"H Li","year":"2012","unstructured":"Li, H., Xie, Y. H., Yang, Q., Wang, S. W., Zhang, B. L., Wang, J. B., et al. (2012). Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS ONE,7(11), e48872.","journal-title":"PLoS ONE"},{"issue":"8","key":"9548_CR36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1253\/circj.CJ-15-0589","volume":"79","author":"DK Gupta","year":"2015","unstructured":"Gupta, D. K., & Wang, T. J. (2015). Natriuretic peptides and cardiometabolic health. Circulation Journal,79(8), 1647\u20131655.","journal-title":"Circulation Journal"},{"issue":"7544","key":"9548_CR37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nature14373","volume":"519","author":"M Kuhn","year":"2015","unstructured":"Kuhn, M. (2015). Cardiology: A big-hearted molecule. Nature,519(7544), 416.","journal-title":"Nature"},{"key":"9548_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jep.2016.03.015","volume":"186","author":"HP Mao","year":"2016","unstructured":"Mao, H. P., Wang, X. Y., Chang, Y. X., Chen, L., Niu, Z. C., Ai, J. Q., et al. (2016). Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-\u03bab pathway. Journal of Ethnopharmacology,186, 20\u201329.","journal-title":"Journal of Ethnopharmacology"},{"key":"9548_CR39","doi-asserted-by":"crossref","first-page":"34790","DOI":"10.1038\/srep34790","volume":"6","author":"Y Ryu","year":"2016","unstructured":"Ryu, Y., Jin, L., Kee, H. J., Piao, Z. H., Cho, J. Y., Kim, G. R., et al. (2016). Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Scientific Reports,6, 34790.","journal-title":"Scientific Reports"},{"issue":"12","key":"9548_CR40","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1021\/jf900549c","volume":"57","author":"C Angeloni","year":"2009","unstructured":"Angeloni, C., Leoncini, E., Malaguti, M., Angelini, S., Hrelia, P., & Hrelia, S. (2009). Modulation of phase II enzymes by sulforaphane: Implications for its cardioprotective potential. Journal of Agricultural and Food Chemistry,57(12), 5615\u20135622.","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"8","key":"9548_CR41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon, M., Looi, Y. H., & Shah, A. M. (2007). Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart,93(8), 903\u2013907.","journal-title":"Heart"},{"key":"9548_CR42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.biopha.2017.08.009","volume":"94","author":"ZW Wong","year":"2017","unstructured":"Wong, Z. W., Thanikachalam, P. V., & Ramamurthy, S. (2017). Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review. Biomedicine & Pharmacotherapy,94, 1145\u20131166.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1\u20132","key":"9548_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.04.035","volume":"107","author":"BD Sahu","year":"2014","unstructured":"Sahu, B. D., Anubolu, H., Koneru, M., Kumar, J. M., Kuncha, M., Rachamalla, S. S., et al. (2014). Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: Possible involvement of mitochondrial dysfunction and apoptosis. Life Sciences,107(1\u20132), 59\u201367.","journal-title":"Life Sciences"},{"issue":"4","key":"9548_CR44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10715761003610760","volume":"44","author":"J Takebayashi","year":"2010","unstructured":"Takebayashi, J., Ishii, R., Chen, J., Matsumoto, T., Ishimi, Y., & Tai, A. (2010). Reassessment of antioxidant activity of Arbutin: Multifaceted evaluation using five antioxidant assay systems. Free Radical Research,44(4), 473\u2013478.","journal-title":"Free Radical Research"},{"issue":"12","key":"9548_CR45","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell, N. H., Tang, G., Yu, C., Mercurio, F., DiDonato, J. A., & Lin, A. (2001). Activation of NF-\u03baB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proceedings of the National Academy of Sciences,98(12), 6668\u20136673.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"9548_CR46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ejhf.942","volume":"19","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Bauersachs, J., & Langer, H. F. (2017). Immune mechanisms in heart failure. European Journal of Heart Failure,19(11), 1379\u20131389.","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"9548_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","volume":"19","author":"LF Shirazi","year":"2017","unstructured":"Shirazi, L. F., Bissett, J., Romeo, F., & Mehta, J. L. (2017). Role of inflammation in heart failure. Current Atherosclerosis Reports,19(6), 27.","journal-title":"Current Atherosclerosis Reports"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09548-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-019-09548-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09548-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:05:54Z","timestamp":1664276754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-019-09548-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9548"],"URL":"https:\/\/doi.org\/10.1007\/s12012-019-09548-3","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,4]]},"assertion":[{"value":"4 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}